Recent studies have shown that higher-order epistasis is ubiquitous and can have large effects on complex traits. Yet, we lack frameworks for understanding how epistatic interactions are influenced by basic aspects of cell physiology. In this study, we assess how protein quality control machinery-a critical component of cell physiology-affects epistasis for different traits related to bacterial resistance to antibiotics. Specifically, we attempt to disentangle the interactions between different protein quality control genetic backgrounds and two sets of mutations: (i) SNPs associated with resistance to antibiotics in an essential bacterial enzyme (dihydrofolate reductase, or DHFR) and (ii) differing DHFR bacterial species-specific amino acid background sequences (Escherichia coli, Listeria grayi, and Chlamydia muridarum). In doing so, we add nuance to the generic observation that non-linear genetic interactions are widespread and capricious in nature, by proposing a mechanistically-grounded analysis of how proteostasis shapes epistasis. These findings simultaneously fortify and demystify the role of environmental context in modulating higher-order epistasis, with direct implications for evolutionary theory, genetic modification technology, and efforts to manage antimicrobial resistance. 5 Otwinowski et al., 2018). Epistasis, informally defined as the "the surprise at the phenotype when mutations are 6 combined, given the constituent mutations' individual effects" (Weinreich et al., 2013) is now a highly relevant 7 frontier of evolutionary genetics. It casts an uncertainty shadow over many areas of biology aiming to understand 8 or manipulate genetic variation (e.g. GWAS, genetic-modification), as it speaks to unpredictability regarding 9 how phenotypes are related to the genes that are presumed to underlie them. 10 An especially provocative related phenomenon is "higher-order epistasis." It offers that parcels of genetic 11 information not only interact in a pairwise fashion (e.g. mutation A interacting non-linearly with mutation B; 12 mutation B interacting non-linearly with mutation C) but potentially in all possible combinations, each with 13 a potentially unique statistical effect (e.g. when the interaction between all 3 mutations-A, B and C-has a 14 quantitative value that cannot be reduced to a combination of independent or pairwise effects) (Weinreich et al., 15 2013; Poelwijk et al., 2016; Crona et al., 2017; Sailer and Harms, 2017). Statistically, higher-order epistasis is 16 an unwieldy concept because the number of possible interactions can grow exponentially with the number of 17 interacting parcels, which presents both conceptual and computational challenges (as it is a mental challenge 18 to keep track of thousands of potential interactions, and computationally challenging to analyze them using 19 available technology). 20 proteostasis shapes higher-order epistasis Many studies of higher-order epistasis focus on the interactions between suites of SNPs associated with 21 a certain phenotype, engineered in combination or via a library of mutations using high-throughput methods 22 (Ferretti et al., 2016; Poelwijk et al., 2016; Crona et al., 2017; Domingo et al., 2018; Otwinowski et al., 2018; 23 Tamer et al., 2018). Fewer studies specifically dissect the strength and sign of epistatic interactions between SNPs 24 within a gene and particular suites of mutations or gene deletions in other parts of the genome (Williams et al., 25 2005; Lehner, 2011; Vogwill et al., 2016). Even fewer dissect the impact of physiological contexts on epistasis, a 26 glaring omission when you consider the biochemical and biophysical specifics of the cellular environment in 27 which genes and proteins are made and function. 28 One particular context that we might predict would shape epistasis within a cell would be that dictated by 29 sets of chaperones and proteases, which have already been demonstrated to have a profound impact on a range of 30 bacterial phenotypes (Gottesman et al., 1997). Prior studies focusing on the chaperonins GroEL/ES and Lon 31 protease have established their centrality in regulating the presence and state of only certain proteins in the 32 cytoplasm (Hartl et al., 2011). And even more recent studies have uncovered how only members of this protein 33 quality control (PQC) system (GroEL/ES and Lon) specifically stabilize different variants of dihydrofolate 34 reductase (Bershtein et al., 2013). The allelic resolution of this proteostasis machinery is a striking finding, and 35 begs the question of how this machinery might frame higher-order epistasis in traits that are controlled by select 36 proteins.
INTRODUCTION 1
Vagarious interactions between parcels of genetic information (e.g. mutations, gene variants, gene networks), 2 as captured in phenomena like pleiotropy and epistasis, are widely recognized as a powerful force in crafting 3 the relationship between genotype and phenotype (Cordell, 2002; Remold and Lenski, 2004; Phillips, 2008;  Script availability 139 All the scripts for these analyses-written in R (R Core Team, 2018) and using methods in the tidyverse 140 (Wickham, 2017) , glmnet (Friedman et al., 2010) , and treemapify (Wilkins, 2018) packages-are available in the 141 Supplement.
142

RESULTS
143
We first set out to construct a coarse picture of the experimental data: whole alleles of DHFR, with SNPs in 144 various combination engineered into several background strains, and assayed for three traits relevant to drug 145 resistance. Figure 1 shows how the engineered alleles (the 8 combinatorial mutants) perform with respect to 146 IC 50 , protein abundance and drugless growth, across genotypic contexts (species and PQC background). While 147 these first two phenotypes show patterns highly consistent with epistatic interactions at several levels, growth 148 rate shows no significant variance across genotype contexts (confirmed by GLM models and BIC model choice;
149 Figure S1 ). 150 Having identified that epistatic interactions are likely to exist in the IC 50 and abundance traits (Figures 1 and 151 S1), we employed a set of regularized regressions to "decompose" the magnitudes, signs and orders of epistatic 152 effects operating at the different scales of genetic parcels represented in this data set (SNPs in DHFR associated 153 with resistance to Trimethoprim, species-specific amino acid background, and PQC mutations). Effect sizes can 154 be found in Tables S1 and S2.
155
Decomposition of epistasis for IC 50 156
The main driver of IC 50 is the species-specific amino acid background (Figure 2A ). The C. muridarum and grayi:GroEL+, effect size = 0.41). As with the main effects, several of these findings might be explained by our 172 4/16 proteostasis shapes higher-order epistasis 
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Figure 1
Phenotypic variation of DHFR mutants across proteostasis contexts. Phenotypes depend on protein quality control context (horizontal axis) and species background (E. coli, green circles; C. muridarum, blue diamonds; L. grayi, in red squares). DHFR mutations at three amino acid positions are represented in binary notation (000=wild type, 001= P21L, 010=A26T, 001=L28T, and their respective double and triple mutants). Points are biological replicates; lines are mean values.
knowledge of the study system. Though there is a basis for the prediction that the amino acid background of L.
grayi and the GroEL+ phenotype would interact (the GroEL+ phenotype helps to stabilize the relatively unstable proteostasis shapes higher-order epistasis effect). The differences in inferred effect sizes suggest that higher-order effects on abundance (P21:A26T:L28R, 202 L. grayi:P21L:L28R, L. grayi:A26T:L28R) need not translate into downstream effects on IC 50 . In other words, 203 we find in these differences some indication of pleiotropy, where mutations (or, in this case, interactions among 204 mutations) display different effects on even functionally-related phenotypes. 
DISCUSSION
222
In this study, we have attempted to dissect the epistatic interactions (in terms of magnitude, sign, and order) 223 operating across SNPs, species-specific amino acid backgrounds, and protein quality control genetic backgrounds 224 for two phenotypes related to drug resistance in bacteria. Below we discuss the major findings, organized into 225 several subsections. Additional discussion points can be found in the Supplemental Information.
226
Higher-order epistasic interactions within and between genes influence two traits related to
227 drug resistance 228 The results speak to the difficulty in making a priori assumptions about the way that epistasis operates when 229 a system contains potential interactions of different kinds (e.g. intragenic and intergenic). If we assume that 230 physical distance between mutations correlates with the strength of interactions, we might guess that individual 231 SNPs within a gene or local amino acids within the same gene (intragenic epistasis) might interact more 232 readily than parcels between loci (intergenic epistasis). This assumption, however, is not supported by our 233 results: we observed that higher-order interactions involving multiple SNPs and PQC backgrounds (i.e., intergenic 234 interactions) can have important effects on several phenotypes, often as large as intragenic interactions. Discussed 
1.22
The L28R mutation greatly increases both structural stability and the drug inhibition constant (K i ), and consequently, helps DHFR perform its enzymatic function in the presence of drug, across genotypic contexts.
L. grayi
Species (main effect) −0.90 The L. grayi amino acid background is very thermodynamically unstable and prone to proteolytic degradation. This is partially compensated for by reasonably high catalytic efficiency (K cat /K m ), but still has a net negative effect on IC 50 . C. muridarum: P21L Species x SNP (second-order) −0.82
The C. muridarum amino acid background is inefficient and thermodynamically unstable. The P21L mutation is, however, slightly stabilizing, which diminishes the negative impact of the C. muridarum amino acid background. The net effect remains negative however. This result highlights how powerful the C. muridarum amino acid background is, in that it can "drag down" the positive effects of certain SNPs. L. grayi:L28R Species x SNP (second-order) −0.69 This highlights the non-linear interaction between a powerfully positive SNP (L28R) and the strongly negative main effect L. grayi background. That the interaction term is negative highlights that even the stabilizing effects of a positive effect SNP (L28R) cannot compensate for the negative effects of the unstable L. grayi amino acid background.
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proteostasis shapes higher-order epistasis and Lon proteases were shown to be major modulators of the total intracellular DHFR abundance, acting upon 454 partially unfolded protein intermediates to either promote folding or proteolytic degradation, respectively. The Figure S1 . Based on the Bayesian inference criteria (BIC), drugless growth rate has no higher-order interactions, and very few significant main effect drivers. This is in stark contrast to the IC 50 and abundance phenotypes, both which of contain several higher-order interactions.
